Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Archive

BioHarvest Sciences Q1 2023 financials shows continued growth with a 209% increase over Q1 2022

BioHarvest Sciences Q1 2023 financials shows continued growth with a 209% increase over Q1 2022

BioHarvest Sciences CEO Ilan Sobel joined Steve Darling from Proactive to share news the company has released its 2023 1st quarter financial numbers that shows big gains over 2022. The company saw VINIA revenues growing 209% compared to Q1 2022 reaching 2.2 million dollars. Sobel also shared with Proactive the company saw gross margins in Q1 2023 increase to 37%, from 26% in Q1 2022. The company is sticking with its guidance of year-on-year revenue growing 3 X to over 17 million dollars. BioHarvest is looking to be cash flow break even in Q4 2023.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK